Insider: Metzger Michael A Chief Executive Officer - Syndax Pharmaceuticals Inc
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 298,661 | 0 | 298,661 |
| Value | $4,499,327.97 | $0.00 | $4,499,327.97 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/08/2025 | DDS | 157,307 | Direct | COM | $16.41 | $2,582,021.37 | 298,661 |
| 07/16/2025 | DDS | 7,534 | Direct | COM | $9.29 | $69,953.19 | 298,661 |
| 03/04/2025 | DDS | 7,814 | Direct | COM | $15.05 | $117,563.97 | 300,121 |
| 02/10/2025 | DDS | 13,288 | Direct | COM | $15.50 | $206,017.15 | 300,121 |
| 02/06/2023 | DDS | 5,959 | Direct | COM | $27.64 | $164,697.23 | 17,659 |
| 10/06/2022 | DDS | 16,231 | Direct | COM | $25.29 | $410,507.96 | 17,659 |
| 10/04/2022 | DDS | 1,280 | Direct | COM | $25.02 | $32,026.37 | 17,659 |
| 10/03/2022 | DDS | 2,883 | Direct | COM | $25.01 | $72,106.71 | 17,659 |
| 09/30/2022 | DDS | 29,606 | Direct | COM | $25.02 | $740,756.92 | 17,659 |
| 07/25/2022 | DDS | 19,764 | Direct | COM | $21.06 | $416,138.93 | 17,659 |
| 07/25/2022 | DDS | 11,838 | Direct | COM | $21.06 | $249,253.83 | 17,659 |
| 07/07/2022 | DDS | 100 | Direct | COM | $21.00 | $2,100.00 | 17,659 |
| 07/06/2022 | DDS | 15,009 | Direct | COM | $21.07 | $316,307.17 | 17,659 |
| 12/20/2021 | DDS | 16,000 | Direct | COM | $20.29 | $324,608.00 | 17,659 |
| 12/20/2021 | DDS | 45,000 | Direct | COM | $20.29 | $912,960.00 | 17,659 |
| 12/17/2021 | DDS | 1,676 | Direct | COM | $19.02 | $31,877.18 | 17,659 |
| 12/16/2021 | DDS | 22,715 | Direct | COM | $19.08 | $433,399.93 | 17,659 |
| 12/13/2021 | DDS | 2,045 | Direct | COM | $19.05 | $38,963.79 | 17,659 |
| 12/13/2021 | DDS | 34,564 | Direct | COM | $19.05 | $658,554.80 | 17,659 |
| 10/26/2021 | DDS | 16,296 | Direct | COM | $19.20 | $312,824.53 | 17,659 |
| 10/25/2021 | DDS | 44,704 | Direct | COM | $19.13 | $855,335.04 | 17,659 |
| 09/27/2021 | DDS | 24,437 | Direct | COM | $19.51 | $476,831.85 | 17,659 |
| 09/22/2021 | DDS | 300 | Direct | COM | $19.02 | $5,706.00 | 17,659 |
| 09/21/2021 | DDS | 4,808 | Direct | COM | $19.16 | $92,108.30 | 17,659 |
| 09/20/2021 | DDS | 31,455 | Direct | COM | $19.24 | $605,046.36 | 17,659 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research